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Objectives
• To develop a cost-effective high-throughput approach for molecular diagnosis of genetic diseases that is cheaper and quicker than WES, and less labor-intensive than the gold standard Sanger sequencing • To assess a new technology in 40 patients presenting monogenic forms of diabetes or obesity, of which causal mutations were already known
Methods
We designed a PCR based sequence enrichment panel targeting the exons of 43 known susceptibility genes for monogenic forms of diabetes and obesity. This panel included a total of 970 primer pairs targeting a total of 437kb of sequence.
Each of the 40 samples genomic DNA was processed on the RDT1000 (RainDance). Fragmented gDNA mixed with PCR reagents was processed into microdroplets that were subsequently fused with microdroplets containing the primer library. The resulting microdroplets were subsequently amplified by PCR. Finally, all 40 amplicon enriched samples were sequenced on the HiSeq2000 (Illumina) to a minimum coverage of 100×. 
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